Macular Degeneration / Macular Disease Trials in Maine, United States

With macular degeneration and a variety of other macular related eye diseases becoming a hot bed of research, many clinical trials are taking place. In the state of Maine, United States, there are currently eight registered clinical trials involving macular degeneration and macular eye diseases.

In Maine, United States, there are eight registered clinical trials for macular degeneration and macular related eye diseases. Of these eight clinical trials, six are actively recruiting for study participants.

The clinical trials that require participants are studying macular related eye diseases that include:

  • Neovascular (wet) age-related macular degeneraiton
  • Diabetic Macular Edema
  • Diabetic Retinopathy
  • Macular Edema; and
  • Central Retinal Vein Occlusion

These clinical trials are intervention based, meaning that the participants are assigned by the investigator to a treatment or other intervention for the macular related eye diseases, with the outcomes of the intervention measured.

The following clinical trials are looking for volunteers.

  1. Double-Masked Study of Efficacy and Safety of IVT VEGF Trap-Eye in Subjects with Wet AMD (View 1)
    Condition: Neovascular (Wet) Age-related Macular Degeneration
    Intervention: Biological – VEGF Trap-Eye; Drug Cmparator
  2. Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME Study
    Condition: Diabetic Macular Edema
    Intervention: Drug: Efalizumab; Drug: Ranibizumab
  3. Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
    Condition: Proliferative Diabetic Retinopathy; Diabetic Macular Edema
    Intervention: Drug: Ranibizumab; Drug: Triamcinolone Acetonide; Behavioral: Sham injection
  4. A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO)
    Condition: Macular Edema; Branch Retinal Vein Occlusion
    Intervention: Drug: ranibizumab injection
  5. A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema With Center Involvement Secondary to Diabetes Mellitus (RISE)
    Condition: Macular Edema
    Intervention: Drug: Ranibizumab Injection
  6. A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE)
    Condition: Central Retinal Vein Occlusion; Macular Edema
    Intervention: Drug: ranibizumab injection

These clinical trials in macular degeneration and macular related eye diseases may have conditions and limits placed on who can participate.

Speak Your Mind

*